Quick Answer
CHEMED CORP reported Total Revenue of $2.53 billion for the year ending 2025.
- CHEMED CORP showed an increase of +4.1% in Total Revenue from 2024 to 2025.
- This data is from CHEMED CORP's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $417.44 million | Q1 2018: $439.18 million | Q2 2018: $441.81 million | Q3 2018: $444.15 million | Q1 2019: $462.03 million | Q2 2019: $473.58 million | Q3 2019: $480.61 million | Q1 2020: $515.80 million | Q2 2020: $502.20 million | Q3 2020: $528.30 million | Q1 2021: $527.36 million | Q2 2021: $532.26 million | Q3 2021: $538.67 million | Q1 2022: $530.55 million | Q2 2022: $531.29 million | Q3 2022: $526.47 million | Q1 2023: $560.16 million | Q2 2023: $553.82 million | Q3 2023: $564.53 million | Q1 2024: $589.23 million | Q2 2024: $595.88 million | Q3 2024: $606.18 million | Q1 2025: $646.94 million | Q2 2025: $618.80 million | Q3 2025: $624.90 million.
- Over the full 10 years of available data (2016 to 2025), CHEMED CORP's Total Revenue has grown by 60.4%.
- Historical annual values: Fiscal year 2025: $2.53 billion | Fiscal year 2024: $2.43 billion | Fiscal year 2023: $2.26 billion | Fiscal year 2022: $2.13 billion | Fiscal year 2021: $2.14 billion | Fiscal year 2020: $2.08 billion | Fiscal year 2019: $1.94 billion | Fiscal year 2018: $1.78 billion | Fiscal year 2017: $1.67 billion | Fiscal year 2016: $1.58 billion.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: